SEP 9, 2026 · PHASE 1/2 TRIAL
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
ClinicalTrials.gov
This is a Phase 1/2 trial registration with no posted results; the study is active but not yet recruiting and outcome data are not available.
Reported
Planned enrollment65
PhasePhase 1/2
Primary outcome measure (Phase 1)Incidence of composite serious adverse even…